Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference8 articles.
1. Buske C, Dreyling M, Alvarez-Larrán A, Apperley J, Arcaini L, Besson C, et al. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus. ESMO Open. 2022;7:100403. https://doi.org/10.1016/J.ESMOOP.2022.100403
2. Pagano L, Salmanton-García J, Marchesi F, Blennow O, Gomes da Silva M, Glenthøj A, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey. Blood. 2022;140:2773–87. https://doi.org/10.1182/blood.2022017257
3. Spanjaart AM, Ljungman P, de La Camara R, Tridello G, Ortiz-Maldonado V, Urbano-Ispizua A, et al. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. 2021;35:3585–8.
4. Lemoine J, Bachy E, Cartron G, Beauvais D, Gastinne T, Rubio MT, et al. Causes and risk factors of early and late non-relapse mortality after CD19 CAR T-cell therapy for diffuse large B-cell lymphoma (DLBCL): a Lysa Study from the Descar-T Registry. Blood. 2022;140:1859–61.
5. Agenzia Italiana del Farmaco Determina 15 febbraio 2022 Definizione delle modalita’ e delle condizioni di impiego dell’associazione di anticorpi monoclonali Evusheld (AZD7442; tixagevimab-cilgavimab) ai sensi del decreto 20 gennaio 2022. (Determina n. DG/87/2022) (22A01225). https://www.aifa.gov.it/registri-e-piani-terapeutici1. Accessed 25 Jan 2023.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献